Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
0.0915
-0.0005 (-0.54%)
At close: Dec 5, 2025, 4:00 PM EST
0.0908
-0.0007 (-0.77%)
After-hours: Dec 5, 2025, 7:59 PM EST
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $9.83 million as of December 5, 2025. Its market cap has decreased by -88.72% in one year.
Market Cap
9.83M
Enterprise Value
16.51M
1-Year Change
-88.72%
Ranking
Category
Stock Price
$0.09
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.65M to $9.83M, a decrease of -97.19%. That is a compound annual growth rate of -62.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 9.83M | -88.99% |
| Dec 18, 2024 | 89.30M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.16M | 5.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |